These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Inhibitory potential of repurposed drugs against the SARS-CoV-2 main protease: a computational-aided approach. Fadaka AO; Aruleba RT; Sibuyi NRS; Klein A; Madiehe AM; Meyer M J Biomol Struct Dyn; 2022 May; 40(8):3416-3427. PubMed ID: 33200673 [TBL] [Abstract][Full Text] [Related]
5. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study. Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817 [TBL] [Abstract][Full Text] [Related]
6. Molecular dynamics simulation, 3D-pharmacophore and scaffold hopping analysis in the design of multi-target drugs to inhibit potential targets of COVID-19. Fayyazi N; Mostashari-Rad T; Ghasemi JB; Ardakani MM; Kobarfard F J Biomol Struct Dyn; 2022; 40(22):11787-11808. PubMed ID: 34405765 [TBL] [Abstract][Full Text] [Related]
7. Identification of potential inhibitors for LLM of Kumari R; Dalal V J Biomol Struct Dyn; 2022; 40(20):9833-9847. PubMed ID: 34096457 [No Abstract] [Full Text] [Related]
8. Structure-based drug discovery by targeting Kurosu M Future Med Chem; 2019 May; 11(9):927-933. PubMed ID: 30907628 [No Abstract] [Full Text] [Related]
10. Concise Synthesis of Tunicamycin V and Discovery of a Cytostatic DPAGT1 Inhibitor. Mitachi K; Mingle D; Effah W; Sánchez-Ruiz A; Hevener KE; Narayanan R; Clemons WM; Sarabia F; Kurosu M Angew Chem Int Ed Engl; 2022 Aug; 61(31):e202203225. PubMed ID: 35594368 [TBL] [Abstract][Full Text] [Related]
11. Screening of potential drug for Alzheimer's disease: a computational study with GSK-3 β inhibition through virtual screening, docking, and molecular dynamics simulation. Elangovan ND; Dhanabalan AK; Gunasekaran K; Kandimalla R; Sankarganesh D J Biomol Struct Dyn; 2021 Nov; 39(18):7065-7079. PubMed ID: 32779973 [TBL] [Abstract][Full Text] [Related]
12. Search for potentially biased epidermal growth factor receptor (EGFR) inhibitors through pharmacophore modelling, molecular docking, and molecular dynamics (MD) simulation approaches. Jethwa M; Gangopadhyay A; Saha A J Biomol Struct Dyn; 2023 Mar; 41(5):1681-1689. PubMed ID: 35014597 [TBL] [Abstract][Full Text] [Related]
13. Target-based virtual screening, computational multiscoring docking and molecular dynamics simulation of small molecules as promising drug candidate affecting kinesin-like protein KIFC1. Khan MKA; Ahmad S; Rabbani G; Shahab U; Khan MS Cell Biochem Funct; 2022 Jul; 40(5):451-472. PubMed ID: 35758564 [TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism of inhibition of COVID-19 main protease by β-adrenoceptor agonists and adenosine deaminase inhibitors using Venugopal PP; Chakraborty D J Biomol Struct Dyn; 2022 Jul; 40(11):5112-5127. PubMed ID: 33397209 [TBL] [Abstract][Full Text] [Related]
15. Exploring species-specific inhibitors with multiple target sites on Yuce M; Sarica Z; Ates B; Kurkcuoglu O J Biomol Struct Dyn; 2023 May; 41(8):3496-3510. PubMed ID: 35302925 [TBL] [Abstract][Full Text] [Related]